Avidity Biosciences Stock Price on November 15, 2024
| RNA Stock | USD 43.25 0.69 1.62% |
Below is the normalized historical share price chart for Avidity Biosciences extending back to June 12, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Avidity Biosciences stands at 43.25, as last reported on the 23rd of November, with the highest price reaching 44.03 and the lowest price hitting 41.75 during the day.
If you're considering investing in Avidity Stock, it is important to understand the factors that can impact its price. At this point, Avidity Biosciences is not too volatile. Avidity Biosciences secures Sharpe Ratio (or Efficiency) of 0.0132, which signifies that the company had a 0.0132% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Avidity Biosciences, which you can use to evaluate the volatility of the firm. Please confirm Avidity Biosciences' Downside Deviation of 4.43, mean deviation of 2.9, and Risk Adjusted Performance of 0.0087 to double-check if the risk estimate we provide is consistent with the expected return of 0.0556%.
At present, Avidity Biosciences' Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Other Stockholder Equity is expected to grow to about 1.1 B, whereas Common Stock is forecasted to decline to 7,600. . At present, Avidity Biosciences' Price Book Value Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Earnings To Growth Ratio is expected to grow to 0.32, whereas Price To Sales Ratio is forecasted to decline to 65.66. Avidity Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 28th of June 2013 | 200 Day MA 34.8485 | 50 Day MA 45.3856 | Beta 0.908 |
Avidity |
Sharpe Ratio = 0.0132
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | RNA | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.21 actual daily | 37 63% of assets are more volatile |
Expected Return
| 0.06 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.01 actual daily | 1 99% of assets perform better |
Based on monthly moving average Avidity Biosciences is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Avidity Biosciences by adding it to a well-diversified portfolio.
Price Book 3.3776 | Enterprise Value Ebitda (5.72) | Price Sales 501.9068 | Shares Float 99 M | Wall Street Target Price 68.5455 |
Avidity Biosciences Main Headline on 15th of November 2024
Cofactor Genomics expands clinical use of OncoPrism, as thei... by businesswire.com
Cofactor Genomics, Inc., a clinical-stage company bridging the precision medicine gap by decoding RNA, announced today the validation and launch of On
Avidity Biosciences Valuation on November 15, 2024
It is possible to determine the worth of Avidity Biosciences on a given historical date. On November 15, 2024 Avidity was worth 50.32 at the beginning of the trading date compared to the closed value of 42.18. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Avidity Biosciences stock. Still, in general, we apply an absolute valuation method to find Avidity Biosciences' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Avidity Biosciences where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Avidity Biosciences' related companies.
| Open | High | Low | Close | Volume | |
| 53.55 | 54.24 | 49.81 | 49.97 | 1,763,382 | |
11/15/2024 | 50.32 | 50.32 | 41.84 | 42.18 | 2,000,160 |
| 42.02 | 42.32 | 39.50 | 41.35 | 1,147,672 |
| Backtest Avidity Biosciences | | | Avidity Biosciences History | | | Avidity Biosciences Valuation | Previous | Next |
Avidity Biosciences Trading Date Momentum on November 15, 2024
| On November 18 2024 Avidity Biosciences was traded for 41.35 at the closing time. Highest Avidity Biosciences's price during the trading hours was 42.32 and the lowest price during the day was 39.50 . The net volume was 1.1 M. The overall trading history on the 18th of November 2024 contributed to the next trading period price depreciation. The trading delta at closing time to the next next day price was 1.97% . The overall trading delta to current price is 0.90% . |
Avidity Biosciences Fundamentals Correlations and Trends
By evaluating Avidity Biosciences' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Avidity Biosciences' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Avidity financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Avidity Biosciences Stock history
Avidity Biosciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Avidity is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Avidity Biosciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Avidity Biosciences stock prices may prove useful in developing a viable investing in Avidity Biosciences
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 73 M | 45.2 M | |
| Net Loss | -156.6 M | -148.8 M |
Avidity Biosciences Quarterly Net Working Capital |
|
Avidity Biosciences Stock Technical Analysis
Avidity Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Avidity Biosciences Period Price Range
Low | November 23, 2024
| High |
0.00 | 0.00 |
Avidity Biosciences cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Avidity Biosciences November 23, 2024 Market Strength
Market strength indicators help investors to evaluate how Avidity Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Avidity Biosciences shares will generate the highest return on investment. By undertsting and applying Avidity Biosciences stock market strength indicators, traders can identify Avidity Biosciences entry and exit signals to maximize returns
Avidity Biosciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Avidity Biosciences' price direction in advance. Along with the technical and fundamental analysis of Avidity Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Avidity to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0087 | |||
| Jensen Alpha | (0.18) | |||
| Total Risk Alpha | (0.55) | |||
| Sortino Ratio | (0.02) | |||
| Treynor Ratio | (0) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Avidity Stock analysis
When running Avidity Biosciences' price analysis, check to measure Avidity Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avidity Biosciences is operating at the current time. Most of Avidity Biosciences' value examination focuses on studying past and present price action to predict the probability of Avidity Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avidity Biosciences' price. Additionally, you may evaluate how the addition of Avidity Biosciences to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |